Dr. Noah Bindman, PhD, is currently Scientific Director of ADC Engineering at Pfizer. Noah joined the Oncology Research Unit of Pfizer in 2024 as part of the acquisition of Seagen. Noah previously spent 8 years at Seagen, focused on the development of next-generation MMAE ADCs.